Arranz, Maria J. http://orcid.org/0000-0002-6757-9198
Gonzalez-Rodriguez, Alex
Perez-Blanco, Josefina
Penadés, Rafael
Gutierrez, Blanca
Ibañez, Laura
Arias, Barbara
Brunet, Mercè
Cervilla, Jorge
Salazar, Juliana
Catalan, Rosa
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI11/02006, PI11/02006, PI11/02006, PI16/01029, PI11/02006)
Article History
Received: 15 January 2019
Revised: 9 May 2019
Accepted: 31 May 2019
First Online: 25 July 2019
Conflict of interest
: M.J.A. consulted for Brainco, the company commercialising the pharmacogenetic test used in the study. However, the company closed in 2014 and did not influence in any way the results of this study. R.C. has received honoraria or travel grants from Janssen, Pfizer, Ferrer, Adamed and Lundbeck-Otsuka. A.G.-R. has received honoraria and/or travel grants from Janssen, Pfizer, Ferrer and Lundbeck-Otsuka.